Earlier this year, Brenda Fitzgerald, the director of the U.S. Centers for Disease Control, was forced to resign because, shortly after taking the position, she had purchased stock in tobacco and pharmaceutical companies — transactions that created a glaring conflict of interest between her financial holdings and her official role.
Originally published in Law360 - May 25, 2018.
Please see full publication below for more information.
